Skip to main content
TOPICS
Videos
Podcasts
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
LifeSci Venture Partners
Cala Health's $50M Series C will bring its wearable essential tremor therapy to market
By
Dave Muoio
|
01:03 pm |
May 21, 2019
The neuromodulation company will also be looking to expand the rest of its product pipeline.